These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 18959123)
1. beta-Secretase inhibitor increases amyloid-beta precursor protein level in rat brain cortical primary neurons induced by okadaic acid. Yu CJ; Wang WZ; Liu W Chin Med J (Engl); 2008 Aug; 121(15):1439-44. PubMed ID: 18959123 [TBL] [Abstract][Full Text] [Related]
2. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Yoon SY; Choi JE; Yoon JH; Huh JW; Kim DH Neurobiol Dis; 2006 May; 22(2):435-44. PubMed ID: 16480887 [TBL] [Abstract][Full Text] [Related]
3. Characterization of V642I-AbetaPP-induced cytotoxicity in primary neurons. Niikura T; Yamada M; Chiba T; Aiso S; Matsuoka M; Nishimoto I J Neurosci Res; 2004 Jul; 77(1):54-62. PubMed ID: 15197738 [TBL] [Abstract][Full Text] [Related]
5. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease. Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883 [TBL] [Abstract][Full Text] [Related]
6. Reversible in vivo phosphorylation of tau induced by okadaic acid and by unspecific brain lesion in rat. Janke C; Gärtner U; Holzer M; Arendt T J Hirnforsch; 1998; 39(2):143-53. PubMed ID: 10022338 [TBL] [Abstract][Full Text] [Related]
8. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
9. zVLL-CHO at low concentrations acts as a calpain inhibitor to protect neurons against okadaic acid-induced neurodegeneration. Yoon SY; Choi JE; Ham JH; Choe H; Lee HS; Kim DH Neurosci Lett; 2012 Feb; 509(1):33-8. PubMed ID: 22230892 [TBL] [Abstract][Full Text] [Related]
10. Amyloid-β Modulates Both AβPP and Tau Phosphorylation. Oliveira JM; Henriques AG; Martins F; Rebelo S; da Cruz e Silva OA J Alzheimers Dis; 2015; 45(2):495-507. PubMed ID: 25589714 [TBL] [Abstract][Full Text] [Related]
11. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing. Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369 [TBL] [Abstract][Full Text] [Related]
12. The protective effect of Rho-associated kinase inhibitor on aluminum-induced neurotoxicity in rat cortical neurons. Chen TJ; Hung HS; Wang DC; Chen SS Toxicol Sci; 2010 Jul; 116(1):264-72. PubMed ID: 20395307 [TBL] [Abstract][Full Text] [Related]
13. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase. Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119 [TBL] [Abstract][Full Text] [Related]
14. Effect of the beta secretase-1 inhibitor on the amyloid C-terminal fragment of amyloid precursor protein processing in a hyperphosphorylated tau rat model. Chen HY; Wang L; Liu JF; Wang WZ; Yu CJ Genet Mol Res; 2014 Aug; 13(3):6213-27. PubMed ID: 25158248 [TBL] [Abstract][Full Text] [Related]
15. Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein. Heredia L; Lin R; Vigo FS; Kedikian G; Busciglio J; Lorenzo A Neurobiol Dis; 2004 Aug; 16(3):617-29. PubMed ID: 15262274 [TBL] [Abstract][Full Text] [Related]
16. Induction of amyloid precursor protein by the neurotoxic peptide, amyloid-beta 25-35, causes retinal ganglion cell death. Tsuruma K; Tanaka Y; Shimazawa M; Hara H J Neurochem; 2010 Jun; 113(6):1545-54. PubMed ID: 20374419 [TBL] [Abstract][Full Text] [Related]
17. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition. Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920 [TBL] [Abstract][Full Text] [Related]
18. Effects of peptides derived from BACE1 catalytic domain on APP processing. Yeon SW; Jeon YJ; Hwang EM; Kim TY Peptides; 2007 Apr; 28(4):838-44. PubMed ID: 17293005 [TBL] [Abstract][Full Text] [Related]
19. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
20. Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons. Patil S; Sheng L; Masserang A; Chan C Neurosci Lett; 2006 Oct; 406(1-2):55-9. PubMed ID: 16904262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]